PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Org Lett. Author manuscript; available in PMC 2010 June 4.
Published in final edited form as:
PMCID: PMC2702139
NIHMSID: NIHMS114782

Accessing Skeletal Diversity Using Catalyst Control: Formation of n and n + 1 Macrocyclic Triazole Rings

Abstract

An external file that holds a picture, illustration, etc.
Object name is nihms-114782-f0001.jpg

A regioselective intramolecular Huisgen cycloaddition was performed on various azido alkyne substrates giving rise to macrocyclic triazole rings. Using catalyst control, a common intermediate has been converted to two structurally unique macrocycles with either a 1,5- or a 1,4-triazole resulting in an n or n + 1 ring size. This is the first example of an intramolecular ruthenium-catalyzed Huisgen cycloaddition.

The preparation and screening of small molecules constitutes a powerful strategy for the discovery of biological probes and pharmaceutical agents.1-3 Diversity of structure within a particular compound collection is key to the discovery of hits over a wide range of biological areas. It has recently been shown that even large screening collections that lack diversity are insufficient to provide lead compounds against a range of antibacterial targets.4 A current strategy for achieving diverse compound collections through diversity-oriented synthesis (DOS) focuses on the use of functional group pairing.5,6 By using scaffolds with multiple functional group “handles” and joining them in a pairwise, intramolecular, and chemoselective fashion both skeletal diversity and rigidity are achieved. A complementary approach for generating structural diversity is known as “reagent-based” diversification.7 This strategy involves the preparation of a singular scaffold that, when subjected to different reaction conditions, selectively yields different products.1,8 To further develop this strategy, robust methodologies that allow for reagent-based differentiation must be developed.

The Huisgen 1,3-dipolar cycloaddition is a widely utilized reaction in DOS.9,10 This `click' reaction results from the ligation of azides and alkynes to give a triazole moiety. This reaction has been shown to be effective in the formation of a variety of macrocyclic rings.11 A key point of interest for us was the regioselectivity of the cycloaddition. We surmised that a reagent-based diversity approach could be applied to generate both possible regioisomers from a common substrate as shown in Scheme 1. While many advances have been made in the formation of 1,4-triazoles using copper (I) catalysis,9 the formation of 1,5-triazole rings using ruthenium (II) catalysis has only recently been reported and has been demonstrated in an intermolecular fashion and in a much more limited scope.10,12

Scheme 1
Use of Huisgen cycloaddition for divergent pairing

With this in mind, we sought to expand the existing Huisgen methodology to make macrocyclic triazole rings regioselectively. This method is ideally suited to the preparation of small-molecule libraries, because one compound can be converted into two structurally unique macrocycles that have an n or n + 1 ring size (Scheme 1). Access to macrocyclic triazoles that are different yet structurally related could provide insight into antibacterial and cytotoxic biological activity, two areas in which triazole-containing small molecules have shown promise.13,14

To explore the substrate scope of this divergent pairing strategy we synthesized various alkynyl azides embedded within different structural frameworks (Scheme 2). The first pairing partner was provided by coupling an amino alcohol (1a) to an azido acyl chloride, resulting in the amide (2a). The second requisite functional group, the alkyne, was added via propargylation of the alcohol (3a). This general synthesis was applied to all of our substrates except in the synthesis of the linear (3e-g) and cyclohexyl substrates (3j-k), in which we observed bisacylation. In this instance, protection of the alcohol as a silyl ether was necessary to avoid ester formation.15

Scheme 2
Substrate synthesis and intramolecular Ru-catalyzed cycloaddition

Using the pyrrolidine azido alkyne substrate (3a), different conditions were screened for the macrocyclic triazole formation. First, we examined the ruthenium (II) catalyzed formation of the 1,5-triazole. When Cp*RuCl(COD) (Table 1, entries 1 and 2) was employed as the catalyst,9 the reaction yielded no product even at elevated temperatures, most likely due to catalyst thermal instability.12 More encouraging results were acheived with Cp*RuCl(PPh3) (Table 1, entry 3), however, 50% dimer formation was observed and purification of the desired product proved difficult due to the presence of phosphine oxide. Improved results were obtained with the [Cp*RuCl]4 catalyst (Table 1, entries 4-8) which yielded improved monomer to dimer ratios (entries 5 and 8) and a more straightforward purification. Using 5% [Cp*RuCl]4 (Table 1, entries 6-8) we found that higher temperatures (80 °C) and lower concentrations (0.002 M) (entry 8) led to optimal monomer to dimer ratios. With our optimized protocol in hand, we obtained the desired 1,5-macrocyclic triazole 4a in 58% isolated yield and confirmed the structure as the 1,5-regioisomer via X-ray crystallography (Figure 1).15 To the best of our knowledge, this is the first demonstration of a ruthenium-catalyzed intramolecular 1,5-triazole formation.

Figure 1
X-ray crystal structures of representative macrocyclic triazoles (4a and 5f)
Table 1
Optimization of Ru-catalyzed cycloaddition to yield 4aa

Using the same pyrrolidine substrate (3a) we attempted to find the best conditions for the formation of the 1,4-triazole. Starting with Cu(CN)4PF6, we ran the reaction at 0.01 M in toluene at 60 °C and saw complete consumption of starting material but no desired product (Table 2, entry 1). It was determined this was due to the intermolecular formation of dimers and oligomers; therefore, we decreased the concentration of the reaction to favor the intramolecular reaction. Gratifyingly, by changing the reaction concentration from 0.01 M to 0.002 M we were able to obtain the 1,4-triazole 5a in 50% yield (Table 2, entry 2). Although encouraged by these results, such dilute conditions were not suitable for the scalability of our protocol, so we sought to optimize the reaction further.

Table 2
Optimization of intramolecular Cu-catalyzed cycloaddition

A recent publication by Girard and coworkers showcased the utility of CuI loaded on Amberlyst resin as a catalyst for an intermolecular Huisgen cycloaddition.16 We envisioned utilizing this technology to facilitate pseudodilution and suppress dimer formation in the intramolecular Huisgen reaction.17 First, we examined the exact conditions reported in the manuscript, Amberlyst-21 and CuI at 0.2 mmol/g loading (Table 2, entry 3). The monomeric 1,4-triazole was obtained, however there was evidence of iodine incorporation.15 While this observation is not uncommon in the use of solution phase CuI, it was not reported by Girard with the solid-phase catalyst. In light of this problem, we applied the Girard protocol to the generation of a CuPF6 Amberlyst. We chose CuPF6 (as opposed to CuBr) due to its high solubility in CH3CN, the solvent used in the preparation of the solid-supported copper reagents. We were pleased to find that using this catalyst (0.2 mmol/g loading) we were able to achieve a 5-fold increase in reaction concentration along with a slight increase in yield for the desired product (Table 2, entry 4). These observations were consistent with pseudodilution.17

With these optimized conditions in hand, the effect of substrate specificity, conformation, and ring size on these metal-catalyzed macrocyclizations was investigated. The results of these experiments are shown in Table 3. The same pyrrolidine system was examined with an additional methylene group in the azido acid side chain (Table 3, entries 4-6). The isolated yields for the formation of the 12- and 13-membered rings were slightly higher than that of the 11- and 12-membered rings, a trend which is consistent with thermodynamic arguments.18

Table 3
Results for intramolecular cycloadditions with linear and carbocyclic substratesa

Since the pyrrolidine substrates (3a-b) assume a pseudo axial position, the piperidine azido alkynes (3c-d) were synthesized in order to examine the effect of a true axial substituent on ring closure. The resulting yields of the cycloaddition were slightly lower than that of their pyrrolidine counterparts (Table 3, entries 7-12). The drop in yield is most likely due to the difficulty of the cycloaddition. We hypothesize that the axial substituent places the alkyne and the azide further apart and leads to greater dimer and oligomer formation.

Three linear substrates (3e-g) were then tested to see if the rigidity imparted by the pyrrolidine ring was facilitating macrocyclization. The results of the metal-catalyzed cyclizations were very similar to that of the pyrrolidine substrate; however, the inherent bias in the system, determined by the thermal reaction, seemed to be less specific. When exposed to the thermal conditions the pyrrolidine substrates formed the 1,5-triazole products almost exclusively; whereas, the linear substrates gave a 4:1 ratio of the 1,5- to 1,4-triazoles (Table 3, entries 3 and 6 vs. 15 and 18). We also compared substrates derived from 1,2-amino alcohols (3e-f) to substrates derived from 1,3-amino alcohols (3g) to determine if the position of the oxygen in the macrocyclic ring had any effect on the cycloaddition. The 1,3-amino alcohols (Table 3, entries 19 and 20) were only slightly higher in yield than their 1,2-amino alcohol counterparts (entries 16 and 17) and their thermal ratios were quite similar (entries 18 and 21). From these observations, it would not seem that the position of the alcohol has a dramatic effect on the macrocyclization. During the course of our work an X-ray crystal structure was obtained for one of the 1,4-triazoles (5f, Figure 1).

With the general reaction conditions established for the regioselective triazole pairing reactions, we chose to further explore conformational effects, as well as examine stereochemical effects on the macrocyclic triazole ring formation. Our results of these experiments are shown in Table 4. The first system that we examined was the planar 2-aminophenol derivatives (Table 4, entries 1-6). To better understand the system, we studied both the primary (Table 4, entries 1-3) and secondary amides (entries 4-6), however, no trend was observed. Both of these substrates gave moderate yields in all cases except for the copper-catalyzed primary amide (Table 4, entry 2). Next, we examined a saturated system of the cis- and trans-cyclohexyl amino alcohol compounds (Table 4, entries 7-12). Surprisingly, the cis or trans configuration had little effect for the ruthenium-catalyzed reaction (Table 4, entries 7 and 10); however, the trans system showed a remarkable loss in yield for the copper-catalyzed case (Table 4, entry 8). Optimization of this reaction for this substrate was effected by a 5-fold dilution, leading to a significant increase in yield, from 17% to 46% (Table 4, entry 8).

Table 4
Influence of stereochemistry on intramolecular cycloadditionsa

In conclusion, we have expanded on the existing Huisgen cycloaddition methodology, showing the utility of pseudodilution and performing the first example of a ruthenium-catalyzed intramolecular cyclization. Furthermore, as a result of this study, we have developed an understanding of which substrates and ring sizes provide the best yields. The performance of these regioisomeric triazoles in a wide variety of biological screens is currently under investigation. We are also following up these substrate examples with a more comprehensive library synthesis, the results of which will be reported in due course.

Supplementary Material

1_si_001

2_si_002

Acknowledgments

Acknowledgment We gratefully acknowledge Marie Harton for help with characterization and Dr. Peter Mueller for X-ray analysis. This work was funded in part by the NIGMS-sponsored Center of Excellence in Chemical Methodology and Library Development (Broad Institute CMLD; P50 GM069721).

Footnotes

Supporting Information Available Experimental procedures, compound characterization data and X-ray crystallographic information files. This material is available free of charge via the Internet at http://pubs.acs.org.

References

1. Burke MD, Schreiber SL. Agnew. Chem. Int. Ed. 2004;43:5178.
2. Burke MD, Berger EM, Schreiber SL. Science. 2003;302:613. [PubMed]
3. Ortholand J, Ganesan A. Curr. Opin. Chem. Bio. 2004;8:270.
4. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Nature Reviews Drug Discovery. 2007;6:29. [PubMed]
5. Comer E, Rohan E, Deng L, Porco JA. Org. Lett. 2007;9:2123–2126. [PubMed]
6. Nielsen TE, Schreiber SL. Agnew. Chem. Int. Ed. 2008;47:48. [PMC free article] [PubMed]
7. Brummond KM, Chen D. Org. Lett. 2008;10:705. [PubMed]
8. Brummond KM, Mitasev B. Org. Lett. 2004;6:2245. [PubMed]
9. Wu P, Fokin VV. Aldrichimica ACTA. 2007;40:7.
10. Zhang L, Chen X, Xue P, Sun HHY, Williams ID, Sharpless KB, Fokin VV, Jia G. J. Am. Chem. Soc. 2005;127:15998. [PubMed]
11. (a) Looper RE, Pizzirani D, Schreiber SL. Org. Lett. 2006;8:2063. [PubMed] (b) Bodine KD, Gin DY, Gin MS. J. Am. Chem. Soc. 2004;126:1638. [PubMed] (c) Bock VD, Perciaccante R, Jansen TP, Hiemstra H, van Maarseveen JH. Org. Lett. 2006;8:919. [PubMed] (d) Turner RA, Oliver AG, Lokey RS. Org. Lett. 2007;9:5011. [PubMed]
12. Boren BC, Narayan S, Rasmussen LK, Zhang L, Zhao H, Lin Z, Jia G, Fokin VV. J. Am. Chem. Soc. 2008;130:8923. [PubMed]
13. (a) Reck F, Zhou F, Girardot M, Kern G, Eyermann CJ, Hales NJ, Ramsay RR, Gravestock MB. J. Med. Chem. 2005;48:499. [PubMed]Horne WS, Olsen CA, Beierle JM, Montero A, Ghadiri MR. Agnew. Chem. Int. Ed. 2009. 48:ASAP.
14. Odlo K, Hentzen J, Chabert J. F. d., Ducki S, Gani OABSM, Sylte I, Skrede M, Flørenesd VA, Hansena TV. Bioorg. Med. Chem. 2008;16:4829. [PubMed]
16. Girard C, Onen E, Aufort M, Beauviere S, Samson E, Herscovici J. Org. Lett. 2006;8:1689. [PubMed]
17. For an example of pseudodilution see: Gonthier E, Breinbauer R. Mol. Diversity. 2005;9:51. [PubMed]
18. Galli C, Mandolini L. Eur. J. Org. Chem. 2000:3117.